News

This week's video covers need-to-know news items related to Tesla (NASDAQ: TSLA) during the week of April 8.

You can find last week's summary here.

*Stock prices used were from the trading day of

Analysts at Mizuho have become a bit less optimistic about Confluent (NASDAQ: CFLT). On Monday, they lowered their price target on the data streaming company's shares from $38 to $36. However, that

In this video, I will talk about four companies that are worth your attention, especially since all of them look oversold. I chose a mix of companies in different industries that could provide

Fool.com contributor Parkev Tatevosian compares Snowflake (NYSE: SNOW) and Palo Alto Networks (NASDAQ: PANW) to determine the better buy for growth stock investors.

*Stock prices used were the

Shares of Reddit (NYSE: RDDT) have plunged from the peak they touched soon after the social media company went public in March. While an initial surge sent Reddit stock to nearly $75 per share, it's

Fool.com contributor Parkev Tatevosian forecasts where Rivian (NASDAQ: RIVN) stock could be in 2027.

*Stock prices used were the afternoon prices of April 11, 2024. The video was published on April

Fool.com contributor Parkev Tatevosian evaluates Tesla's (NASDAQ: TSLA) earnings prospects over the near term.

*Stock prices used were the afternoon prices of April 11, 2024. The video was

Sometimes it pays to team up. That's what Novo Nordisk (NYSE: NVO) and Ginkgo Bioworks (NYSE: DNA) decided to do April 10 when they launched a new manufacturing collaboration that could benefit both

With its shares up by over 4,000% in the past five years, an investment in Super Micro Computer (NASDAQ: SMCI) has been life changing for early investors. To put things in perspective, a $1,000

Investors have been treading carefully around big pharma stocks, except a few like Eli Lilly and Novo Nordisk, the makers of weight-loss medications Zepbound and Wegovy, respectively. The high-risk

Are you kicking yourself, thinking that you missed out on the recent bull market recovery? Well, stop that.

Yes, the stock market, as measured by the S&P 500 index (which features about 500

Biotech acquisitions continue to abound this year. On April 10, Vertex Pharmaceuticals (NASDAQ: VRTX) announced it would purchase Alpine Immune Sciences (NASDAQ: ALPN) for $4.9 billion in cash in a

Rivian (NASDAQ: RIVN) and Nikola (NASDAQ: NKLA) were once two of the market's hottest electric vehicle stocks. Rivian went public in Nov. 2021, and it soared from its IPO price of $78 to a record

Investing in Starbucks (NASDAQ: SBUX) stock has been a frustrating experience in recent times. Its shares have climbed by just 12% in the past five years -- seriously lagging the broader S&P 500's

The pharmaceutical industry is currently grappling with a major investment problem. Since 2004, the shares of most major pharmaceutical companies have been lagging behind the S&P 500. A few

Pfizer (NYSE: PFE) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on hopes for its coronavirus vaccine, new sources of growth haven't led to

Dividend stocks are ideal for people who are at or near retirement. Compared to their more growth-focused counterparts, these investments tend to involve less risk due to the mature nature of their

If a little bird told you to think about buying Bluebird Bio (NASDAQ: BLUE) stock recently, there's a lot of information you'll need to evaluate. Between the new product that this small biotech has

In 2024, the global semiconductor (or chip) market is projected to grow more than 13% to nearly $600 billion, according to the Semiconductor Industry Association. Moreover, this market should reach